MoonLake Immunotherapeutics Ownership | Who Owns MoonLake Immunotherapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

MoonLake Immunotherapeutics Ownership Summary

MoonLake Immunotherapeutics is owned by 1.43% institutional investors, 9.82% insiders, and 88.76% retail investors. Bvf inc/il is the largest institutional shareholder, holding 31.21% of MLTX shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.64% of its assets in MoonLake Immunotherapeutics shares.

MLTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MoonLake Immunotherapeutics	1.43%	9.82%	88.76%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	19.75M	31.21%	$141.62M
Avoro capital advisors	2.00M	3.16%	$14.34M
Cormorant asset management, lp	1.99M	3.15%	$14.30M
Adage capital partners gp	1.50M	2.37%	$10.76M
Schonfeld strategic advisors	965.40K	1.53%	$6.92M
Price t rowe associates inc /md/	822.96K	1.30%	$5.90M
Fmr	726.93K	1.15%	$5.21M
Nuveen	635.70K	1.00%	$4.56M
Nuveen asset management	595.58K	0.95%	$32.25M
Two sigma investments, lp	454.27K	0.72%	$3.26M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bvf inc/il	19.75M	5.74%	$141.62M
Ghost tree capital	300.00K	4.13%	$13.19M
Lion point capital, lp	67.50K	2.75%	$483.98K
Cormorant asset management, lp	1.99M	0.99%	$14.30M
Exome asset management	178.08K	0.77%	$1.28M
Boxer capital management	250.00K	0.57%	$1.79M
Ikarian capital	435.84K	0.32%	$3.12M
First turn management	262.64K	0.28%	$1.88M
Avoro capital advisors	2.00M	0.19%	$14.34M
Catalio capital management, lp	133.13K	0.18%	$954.55K

Top Buyers

Holder	Shares	% Assets	Change
Adage capital partners gp	1.50M	0.02%	1.50M
Schonfeld strategic advisors	965.40K	0.04%	965.40K
Two sigma investments, lp	454.27K	0.00%	454.27K
Ikarian capital	435.84K	0.32%	435.84K
Balyasny asset management	423.17K	0.03%	344.33K

Top Sellers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	1.99M	0.99%	-6.50M
Fmr	726.93K	0.00%	-5.00M
Avoro capital advisors	2.00M	0.19%	-2.15M
Price t rowe associates inc /md/	822.96K	0.00%	-1.79M
Westfield capital management co lp	-	-	-1.26M

New Positions

Holder	Shares	% Assets	Change	Value
Adage capital partners gp	1.50M	0.02%	1.50M	$10.76M
Ikarian capital	435.84K	0.32%	435.84K	$3.12M
Boothbay fund management	258.78K	0.03%	258.78K	$1.86M
Boxer capital management	250.00K	0.57%	250.00K	$1.79M
Exome asset management	178.08K	0.77%	178.08K	$1.28M

Sold Out

Holder	Change
National bank of canada /fi/	-2.00
Creative financial designs inc /adv	-10.00
Amundi	-12.00
Riggs asset managment	-24.00
Quantbot technologies lp	-49.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	30	-79.31%	901,952	-98.46%	1	0.02%	17	-73.02%	9	-83.64%
Jun 30, 2025	145	-2.03%	58,588,368	-0.85%	92	1.06%	63	-11.27%	54	25.58%
Mar 31, 2025	150	19.05%	59,722,976	-5.57%	94	0.93%	72	-	43	43.33%
Dec 31, 2024	124	6.90%	63,224,599	1.80%	100	1.03%	70	-	30	20.00%
Sep 30, 2024	116	-1.69%	62,108,663	2.42%	98	1.05%	71	20.34%	25	-35.90%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
T. Rowe Price Health Sciences	1.04M	1.64%	-55.57K
Polar Capital Biotech S Inc	1.00M	1.58%	-
Fidelity Growth Compy Commingled Pl S	981.02K	1.54%	273.63K
Fidelity Growth Company Fund	740.92K	1.17%	248.13K
Federated Hermes Kaufmann R	665.00K	1.05%	-
Federated Hermes Kaufmann Growth	665.00K	1.05%	-
US Small-Cap Growth II Equity Comp	523.89K	0.83%	-134.19K
Fidelity Select Health Care	520.00K	0.82%	-150.00K
Fidelity Select Biotechnology	518.86K	0.82%	-86.20K
Federated Hermes Kaufmann Small Cap A	503.00K	0.79%	-16.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 08, 2025	Santos da Silva Jorge	Chief Executive Officer	Sell	$1.96M
Dec 09, 2025	Santos da Silva Jorge	Chief Executive Officer	Sell	$1.01M
Dec 08, 2025	Reich Kristian	Chief Scientific Officer	Sell	$1.96M
Dec 09, 2025	Reich Kristian	Chief Scientific Officer	Sell	$1.05M
Oct 08, 2025	Bodenstedt Matthias	Chief Financial Officer	Buy	$98.81K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	1	4
2025 Q3	-	6
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	4

MLTX Ownership FAQ

Who Owns MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics shareholders are primarily institutional investors at 1.43%, followed by 9.82% insiders and 88.75% retail investors. The average institutional ownership in MoonLake Immunotherapeutics's industry, Biotech Stocks , is 45.22%, which MoonLake Immunotherapeutics falls below.

Who owns the most shares of MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics’s largest shareholders are Bvf inc/il (19.75M shares, 31.21%), Avoro capital advisors (2M shares, 3.16%), and Cormorant asset management, lp (1.99M shares, 3.15%). Together, they hold 37.52% of MoonLake Immunotherapeutics’s total shares outstanding.

Does Blackrock own MoonLake Immunotherapeutics?

BlackRock is not among the top 10 institutional shareholders of MoonLake Immunotherapeutics.

Who is MoonLake Immunotherapeutics’s biggest shareholder by percentage of total assets invested?

Bvf inc/il is MoonLake Immunotherapeutics’s biggest shareholder by percentage of total assets invested, with 5.74% of its assets in 19.75M MoonLake Immunotherapeutics shares, valued at 141.62M$.

Who is the top mutual fund holder of MoonLake Immunotherapeutics shares?

T. Rowe Price Health Sciences is the top mutual fund holder of MoonLake Immunotherapeutics shares, with 1.64% of its total shares outstanding invested in 1.04M MoonLake Immunotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools